Saturday, October 31, 2026

How Celltrion Plans to Cut Biologics Development Costs by 25% Amid FDA Regulation Changes

Celltrion is optimistic about enhanced competitiveness due to eased biosimilar regulations by the FDA, expecting significant cost reductions.

South Korea’s President Lee, Italian Lower House Speaker Discuss Expanding Bilateral Cooperation

President Lee Jae-myung meets Italian Chamber speaker Fontana, discussing parliamentary diplomacy and cultural exchanges between South Korea and Italy.

Experience the Future: HD Construction Machinery’s Mini Electric Excavator HX19E Takes Center Stage at CONEXPO 2026

HD Construction Equipment showcased its electric excavators at CONEXPO 2026, engaging visitors with an Operator Challenge and demos.

Health

Unlock Your Health: Discover the New AI-Powered BioAge and Health Coach Services from DaNaA Data

Daewoo Group's AI health data firm, DaNaA Data, launched a service analyzing biological age, disease risk, and health check results.

How the New Medical School in Namwon Can Transform Regional Healthcare: Insights from Lawmaker Park Ji-won

Defining school locations alone won't solve local healthcare issues; deeper strategies are needed for effective solutions.

Ardens Lifescience Triumphs: How a Korean Startup Won 175,000 USD at MedTech Innovator APAC 2026

Adenz Life Sciences wins a global medical device competition, earning a prize of 175,000 USD.

Unlocking the Future of Healthcare: Daewoong’s AI-Powered Smart Hospital at AI EXPO MARS 2026

Daewoong Pharmaceutical introduces an AI-based smart hospital model for monitoring, diagnosis, testing, and rehabilitation.

10 Years of Excellence: Seoul’s APLAR Center Hosts International Rheumatology Training for Young Specialists

Seoul St. Mary's Hospital's Rheumatology Center held an international training program for foreign experts on October 27 and 26.
Latest

Celltrion Submits U.S. Phase 4 IND for High-Dose 240 mg Zymfentra

Celltrion has submitted a U.S. Phase 4 trial application to support the use of a higher 240 mg dose of Zymfentra, aiming to expand personalized dosing options and strengthen the drug's position in the U.S. market.

Blood Proteins May Offer Clues to Alzheimer’s Antibody Treatment Benefits and Side-Effect Risks

A South Korean study found that blood levels of complement proteins C1q and C3 may help predict amyloid reduction and ARIA risk in patients receiving lecanemab, though larger studies are needed.

Pentrym Confirms Combination Benefits With Existing Cancer Drugs, Targets “False Resistance”

Pentrym is testing whether targeting the tumor microenvironment alongside existing cancer drugs can overcome “false resistance” and improve treatment effectiveness.

YH42946: The Promising HER2 Targeted Oral Treatment Set to Transform Cancer Care in 2026

Yuhan Corporation will reveal early results of its oral HER2-targeted therapy candidate 'YH42946' in clinical trials by year-end.

SK Biopharm Achieves MSCI ESG AAA Rating for 3rd Consecutive Year: What It Means for the Pharma Industry

SK Biopharm has achieved the highest AAA rating in MSCI's ESG evaluation for three consecutive years.

Best Abstract Award at KCR 2026: Discover the Impact of AI on Chest X-Ray Analysis

AI double reading of chest X-rays by doctors recognized at Korea's largest radiology conference for enhancing diagnostic accuracy.

TXN10128: Breakthrough Oral ENPP1 Inhibitor Shows 44.4% Tumor Reduction in EGFR Mutation Lung Cancer

TXINNO Bioscience's new drug trial shows tumor reduction in 4 out of 9 patients with EGFR-mutated lung cancer who failed prior treatments.

How AI is Revolutionizing Digital Health: Insights from Welt CEO Kang Sung-ji

Exploring ways to quickly uncover unknown factors that lead to patient illness and death, driven by medical curiosity.

ASleep vs. Traditional Methods: The Future of Sleep Apnea Diagnosis and Treatment

ASleep partners with Air Liquide Healthcare to expand its sleep apnea screening and patient management services.

SEERS Joins KRX Healthcare Index: What This Means for AI in Medicine

Wearable AI diagnostics firm Cears has been newly included in the KRX Healthcare Index effective from September 11.

Why Tergase is the Best Biotechnology Product of 2026: A Deep Dive into Its Innovations

Alteogen's Terghaz was awarded Best Biotechnology Product at the 2026 Prigalien Korea Awards for its recombinant human hyaluronidase.

Navigating FDA Challenges: How SK Biopharmaceuticals Plans to Move Forward with Opacalim

SK Biopharm will maintain its development and commercialization plans for epilepsy drug candidate Opacalim despite FDA's partial clinical hold.

Yuhan’s Leclaza Wins Best Pharmaceutical Product at Asia’s First Prix Galien Awards

Yuhan Corporation's lung cancer drug 'Lecanza' wins Best Pharmaceutical Product at the inaugural 'Prix Galien' in Asia.

Unlocking Cancer Treatment: How Lunit and 10x Genomics Are Pioneering New Biomarkers for Precision Medicine

Lunit partners with 10x Genomics to discover biomarkers predicting cancer drug effectiveness in patients.

Top News

- Our Sponsors Ad -

Follow us

Cars

Tech

future

health

© Copyright by News1. All Rights Reserved.